Persistence-Targeted Smoking Cessation

Completed · Phase 1

Conditions studied: Tobacco Use Disorder

In brief

The investigators propose to develop a theory-based smoking cessation intervention (called Persistence-targeted smoking cessation; PTSC). PTSC includes 8 weekly individual counseling sessions and use of nicotine lozenge for 12 weeks. The investigators will test the feasibility and preliminary efficacy of the intervention (i.e., cigarettes per day and prolonged abstinence).

Key facts

Study ID

NCT01654107

Run by

Rutgers, The State University of New Jersey

People needed

58

Starts

2012-07-01

Expected to finish

2014-09-01

Last updated by the study team

2017-08-21

Who can join

Age: 18 and older, up to 64. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Must be between 18 - 64 years old
• Must smoke at least 10 cigarettes per day for past 6-months
• Expired breath carbon monoxide (CO) > 7
• Must have a working cellular phone

You may not qualify if…

• Must not be currently receiving tobacco dependence treatment counseling
• Must not currently be taking varenicline, bupropion, or any nicotine preparations (gum, lozenge, patch, spray, inhaler)
• Must have no contraindications to using nicotine lozenge

Where it is running

• Rutgers Robert Wood Johnson Medical School — New Brunswick, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.